Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Magdalena Żemojtel-Piotrowska; Artur Sawicki; Jarosław Piotrowski; Uri Lifshin; Mabelle Kretchner; John J. Skowronski; Constantine Sedikides; Peter Karl Jonason; Mladen Adamovic; Attiso M.G. Agada; Oli Ahmed; Laith Al-Shawaf; Seth Christopher Yaw Appiah; Rahkman Ardi; Uzma Azam; Zana Babakr; Einar Baldvin Baldursson; Sergiu Baltatescu; Tomasz Baran; Konstantin Bochaver; Aidos K. Bolatov; Mario Bonato; Harshalini Y. Bundhoo; Trawin Chaleeraktrakoon; Phatthanakit Chobthamkit; Richard Cowden; Victor Counted; Gisela de Clunie; Sonya Dragova-Koleva; Carla Sofia Esteves; Valdiney V. Gouveia; Katherine Gundolf; Salima Hamouda; Carmen Haretche; Evelyn Hye Kyung Jeong; Dzintra Iliško; Najma Iqbal Malik; John Jamir Benzon Aruta; Fanli Jia; Veljko Jovanović; Tomislav Jukić; Doroteja Pavan Jukić; Shanmukh V. Kamble; Narine Khachatryan; Martina Klicperova-Baker; Christopher Kogler; Emil Knezović; Metodi Koralov; Monika Kovacs; Walaa Labib M. Eldesoki; Aitor Larzabal Fernandez; Kadi Liik; Sadia Malik; Karine Malysheva; John Maltby; Agim Mamuti; Jasmina anon; Chanki Moon; Taciano L. Milfont; Stephan Muehlbacher; Reza Najafi; Emrah Özsoy; Joonha Park; Pablo Pérez de León; Iva Polackova Solcova; Jano Ramos-Diaz; Goran Ridic; Ognjen Riđić; Adil Samekin; Andrej Starc; Delia Stefenel; Kiều Thị Thanh Trà; Habib Tiliouine; Robert Tomšik; Jorge Torres-Marín; Charles S. Umeh; Eduardo Wills-Herrera; Anna Wlodarczyk; Zahir Vally; Christin‐Melanie Vauclair; Illia Yahiiaiev; Somayeh Zand.
ssrn; 2024.
Preprint in English | PREPRINT-SSRN | ID: ppzbmed-10.2139.ssrn.4783160

Subject(s)
COVID-19
2.
medrxiv; 2021.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2021.05.24.21257465

ABSTRACT

The rapid international spread of the SARS-CoV-2 virus 19 led to unprecedented attempts to develop and administer an effective vaccine. However, there is evidence of considerable vaccine hesitancy in some countries and sub-populations. We investigated willingness to vaccinate in three nations with historically different levels of vaccine willingness and attitudes to the COVID-19 vaccine rollout: Israel, Japan and Hungary. Employing an ecological-systems approach we analysed associations between demographic factors and health status, individual cognitions, normative pressures, trust in government, belief in COVID-19 myths and willingness to be vaccinated, using data from three nationally representative samples (Israel, N=1011 (Jan 2021); Japan, N= 997 (Feb 2021); Hungary, N=1131 (Apr 2021)). In Israel 74% indicated a willingness to vaccinate, but only 51% in Japan and 31% in Hungary. Results from multigroup regression analyses indicated greater vaccine willingness amongst those who perceived benefits to vaccination, anticipated regret if not vaccinated and trusted the government. Multi-group latent class analysis of ten COVID-19 (mis)beliefs identified three classes of myths, with concerns about the alteration of DNA (Israel), allergies (Hungary) and catching COVID-19 from the vaccine (Japan) specific to vaccine willingness for each culture. Rather than focusing primarily on disease threats, intervention campaigns should focus on increasing trust and addressing culturally specific myths while emphasising the individual and social group benefits of vaccination.


Subject(s)
COVID-19 , Drug Hypersensitivity
SELECTION OF CITATIONS
SEARCH DETAIL